These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 6225471

  • 1. Somatomedins in Down's syndrome.
    Sara VR, Gustavson KH, Annerén G, Hall K, Wetterberg L.
    Biol Psychiatry; 1983 Jul; 18(7):803-11. PubMed ID: 6225471
    [No Abstract] [Full Text] [Related]

  • 2. The presence of normal levels of serum immunoreactive insulin-like growth factor 2 (IGF-2) in patients with Down's syndrome.
    Annerén G, Enberg G, Sara VR.
    Ups J Med Sci; 1984 Jul; 89(3):274-8. PubMed ID: 6240148
    [Abstract] [Full Text] [Related]

  • 3. [Determination of phospholipids levels in patients with Down's syndrome].
    Iwahashi EE, Santos SR, de Castro Porto G, Rocca Rossi AL.
    Rev Farm Bioquim Univ Sao Paulo; 1976 Jul; 14(1):95-103. PubMed ID: 143047
    [No Abstract] [Full Text] [Related]

  • 4. Serum total tryptophan and free tryptophan concentration in Down's syndrome its relation to serum serotonin concentration.
    Hoshino Y, Kaneko M, Yashima Y, Kumashiro H.
    Fukushima J Med Sci; 1980 Jun; 27(1-2):39-51. PubMed ID: 6460675
    [No Abstract] [Full Text] [Related]

  • 5. Studies in Down's syndrome. IV. Investigations on the "Xh" factor.
    Rittner C, Rittner B.
    Clin Genet; 1973 Jun; 4(5):407-9. PubMed ID: 4270856
    [No Abstract] [Full Text] [Related]

  • 6. Serum levels of osteocalcin (bone Gla protein) in normal children and Down's syndrome.
    Galli M, Caniggia I.
    Panminerva Med; 1987 Jun; 29(2):139-42. PubMed ID: 2957641
    [No Abstract] [Full Text] [Related]

  • 7. [Hemoglobin concentration, hematocrit and leukocyte distribution pattern in children with Down's syndrome].
    Bartelik S.
    Pediatr Pol; 1995 Jun; 70(6):467-71. PubMed ID: 8692603
    [Abstract] [Full Text] [Related]

  • 8. Lymphoid cell lines. Established from peripheral blood of persons with Down's syndrome.
    Woods LK, Moore GE, Bainbridge CJ, Huang CC, Huzella C, Quinn LA.
    N Y State J Med; 1973 Apr 01; 73(7):869-73. PubMed ID: 4266330
    [No Abstract] [Full Text] [Related]

  • 9. [Hyperuricemia in Down's syndrome (etiology, significance, and possibilities of its modification)].
    Kucera J.
    Cesk Pediatr; 1976 Jun 01; 31(6):316-9. PubMed ID: 134841
    [No Abstract] [Full Text] [Related]

  • 10. [On the sex chromatin in leukocytes in Down's syndrome and Turner's syndrome].
    Russkikh VV, Medvedev AV.
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1968 Jun 01; 68(2):237-43. PubMed ID: 4231792
    [No Abstract] [Full Text] [Related]

  • 11. Comparative mortality in mentally retarded patients in California, with and without Down's syndrome, 1986-1991.
    Singer RB, Strauss D.
    J Insur Med; 1997 Jun 01; 29(3):172-84. PubMed ID: 10176367
    [Abstract] [Full Text] [Related]

  • 12. The electroencephalogram in cases with Down's syndrome.
    Uoashi T.
    Bull Osaka Med Sch; 1970 Apr 01; 16(1):1-22. PubMed ID: 4248199
    [No Abstract] [Full Text] [Related]

  • 13. Serum dopamine-beta-hydroxylase activity in Down's syndrome: a familial study.
    Freedman LS, Goldstein M, Coleman M.
    Res Commun Chem Pathol Pharmacol; 1974 Jul 01; 8(3):543-9. PubMed ID: 4277650
    [No Abstract] [Full Text] [Related]

  • 14. [Carnitine and Down's syndrome].
    Colombo ML, Girardo E, Gallo M, Ricci BM, Maina D.
    Minerva Pediatr; 1989 Apr 01; 41(4):173-6. PubMed ID: 2528053
    [Abstract] [Full Text] [Related]

  • 15. Chromosomal damage in lymphocytes of controls and patients with autosomal and sex-chromosomal disorders.
    Ganguly BB, Talukder G, Sharma A.
    Cytobios; 1993 Apr 01; 73(293):95-103. PubMed ID: 8319501
    [Abstract] [Full Text] [Related]

  • 16. The somatomedins throughout development.
    Sara VR, Hall K.
    Bull Schweiz Akad Med Wiss; 1993 Apr 01; ():199-203. PubMed ID: 7184604
    [No Abstract] [Full Text] [Related]

  • 17. Anti-dsDNA autoantibodies in serum of Down's syndrome patients.
    Corsi MM, Marocchi A, Licastro F.
    Clin Chim Acta; 2004 Oct 01; 348(1-2):219-21. PubMed ID: 15369759
    [No Abstract] [Full Text] [Related]

  • 18. [Somatomedins--a review. 2. Age and nutrition dependence, somatomedin concentration in endocrine and non-endocrine diseases].
    Jahreis G, Hesse V.
    Kinderarztl Prax; 1983 Sep 01; 51(9):403-12. PubMed ID: 6656098
    [No Abstract] [Full Text] [Related]

  • 19. Neonatal myeloproliferative disorders in Down's syndrome and congenital leukemias.
    Paolucci G, Rosito P.
    Haematologica; 1987 Sep 01; 72(6 Suppl):121-5. PubMed ID: 2965083
    [No Abstract] [Full Text] [Related]

  • 20. Middle ear effusion in Down's syndrome patients.
    Samuelson ME, Nguyen VT.
    Nebr Med J; 1980 Apr 01; 65(4):83-4. PubMed ID: 6445043
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.